Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Asthma

Free Subscription Articles published in Int Arch Allergy Immunol Retrieve available abstracts of 112 articles: HTML format

Single Articles

November 2024
1. GUO T, Jia G, Wang J, Deng X, et al
   The lung-brain axis: genetic evidence for causal effects of asthma, allergic rhinitis, and chronic rhinosinusitis on brain structure.
   Int Arch Allergy Immunol. 2024 Nov 25:1-18. doi: 10.1159/000542718.
   PubMed     Abstract available
   
   
   
2. VAZQUEZ DE LA TORRE M, Lopez-Gonzalez P, Haroun-Diaz E, Somoza ML, et al
   Depigmented, polymerized cat epithelium extract is safe and improves rhinitis and asthma symptoms in cat allergic patients: A real-world retrospective study.
   Int Arch Allergy Immunol. 2024 Nov 14:1-18. doi: 10.1159/000541838.
   PubMed     Abstract available
   
   
   October 2024
3. WANG S, Zhao J, Xie J
   Targeting Lipid Metabolism in Obese Asthma: Perspectives and Therapeutic Opportunities.
   Int Arch Allergy Immunol. 2024 Oct 18:1-15. doi: 10.1159/000540405.
   PubMed     Abstract available
   
   
   September 2024
4. ZENG Z, Ruan Y, Ying H, Wang J, et al
   Baicalin Attenuates Type 2 Immune Responses in a Mouse Allergic Asthma Model through Inhibiting the Production of Thymic Stromal Lymphopoietin.
   Int Arch Allergy Immunol. 2024 Sep 19:1-9. doi: 10.1159/000541100.
   PubMed     Abstract available
   
   
   
5. YIM Y, Jo H, Park S, Son Y, et al
   Sex-Specific and Long-Term Trends of Asthma, Allergic Rhinitis, and Atopic Dermatitis in South Korea, 2007-2022: A Nationwide Representative Study.
   Int Arch Allergy Immunol. 2024 Sep 16:1-18. doi: 10.1159/000540928.
   PubMed     Abstract available
   
   
   
6. CUI Y, Yu C, Lu Q, Huang X, et al
   The Function of RhoA/ROCK Pathway and MYOCD in Airway Remodeling in Asthma.
   Int Arch Allergy Immunol. 2024 Sep 11:1-17. doi: 10.1159/000540963.
   PubMed     Abstract available
   
   
   
7. DU Y, Yang B, Yao W, Ge L, et al
   Clinical and Immunological Features of Bronchial Asthma Comorbid Chronic Urticaria: A Retrospective Study.
   Int Arch Allergy Immunol. 2024 Sep 3:1-9. doi: 10.1159/000540684.
   PubMed     Abstract available
   
   
   August 2024
8. JHENG MJ, Kita H
   Control of Asthma and Allergy by Regulatory T Cells.
   Int Arch Allergy Immunol. 2024 Aug 16:1-15. doi: 10.1159/000540407.
   PubMed     Abstract available
   
   
   
9. ZHANG Z, Li G, Zhou S, Wang M, et al
   Causal Effects of Asthma on Upper Airway Diseases and Allergic Diseases: A Two-Sample Mendelian Randomization.
   Int Arch Allergy Immunol. 2024 Aug 6:1-10. doi: 10.1159/000540358.
   PubMed     Abstract available
   
   
   June 2024
10. EVCEN R, Colkesen F, Yildiz E, Sadi Aykan F, et al
    Impact of the COVID-19 Pandemic on Cockroach Allergy: A 4-Year Retrospective Study.
    Int Arch Allergy Immunol. 2024 Jun 20:1-8. doi: 10.1159/000539321.
    PubMed     Abstract available
    
    
    
11. WONG QYA, Chew FT
    The Association between Migration and Prevalence of Allergic Diseases: A Systematic Review and Meta-Analysis.
    Int Arch Allergy Immunol. 2024 Jun 20:1-24. doi: 10.1159/000539382.
    PubMed     Abstract available
    
    
    
12. STEFFAN BN, Townsend EA, Denlinger LC, Johansson MW, et al
    Eosinophil-Epithelial Cell Interactions in Asthma.
    Int Arch Allergy Immunol. 2024 Jun 17:1-15. doi: 10.1159/000539309.
    PubMed     Abstract available
    
    
    May 2024
13. LIU Y, Liu H, Shao Q, Shi H, et al
    Majie Cataplasm Alleviates Asthma by Regulating Th1/Th2/Treg/Th17 Balance.
    Int Arch Allergy Immunol. 2024 May 15:1-10. doi: 10.1159/000538597.
    PubMed     Abstract available
    
    
    
14. XU C, Chai D, Zheng P, Qiu R, et al
    The Sensitization Differences of Pollen Allergen Components in Patients with Asthma and/or Rhinitis in Southern China.
    Int Arch Allergy Immunol. 2024 May 3:1-6. doi: 10.1159/000538403.
    PubMed     Abstract available
    
    
    April 2024
15. LIU YL, Zhang Y
    Prediction of Clinical Response to Dupilumab in Patients with Severe Asthma Using Fractional Exhaled Nitric Oxide Combined with Pulmonary Function Testing.
    Int Arch Allergy Immunol. 2024 Apr 30:1-9. doi: 10.1159/000538542.
    PubMed     Abstract available
    
    
    
16. MAO Z, Ding Z, Liu Z, Shi Y, et al
    miR-21-5p Modulates Airway Inflammation and Epithelial-Mesenchymal Transition Processes in a Mouse Model of Combined Allergic Rhinitis and Asthma Syndrome.
    Int Arch Allergy Immunol. 2024 Apr 8:1-11. doi: 10.1159/000538252.
    PubMed     Abstract available
    
    
    
17. JINNO M, Ohta S, Mikuni H, Uno T, et al
    Involvement of Muscarinic M3 Receptor in the Development of M2 Macrophages in Allergic Inflammation.
    Int Arch Allergy Immunol. 2024 Apr 2:1-10. doi: 10.1159/000538126.
    PubMed     Abstract available
    
    
    March 2024
18. HUANG J, Cai H, Ye X, Zhang G, et al
    Demethylzeylasteral (T-96) Alleviates Allergic Asthma via Inhibiting MAPK/ERK and NF-kappaB Pathway.
    Int Arch Allergy Immunol. 2024 Mar 25:1-10. doi: 10.1159/000537837.
    PubMed     Abstract available
    
    
    
19. BOWMAN WS, Schmidt RJ, Sanghar GK, Thompson Iii GR, et al
    "Air That Once Was Breath" Part 2: Wildfire Smoke and Airway Disease - "Climate Change, Allergy and Immunology" Special IAAI Article Collection: Collegium Internationale Allergologicum Update 2023.
    Int Arch Allergy Immunol. 2024 Mar 25:1-14. doi: 10.1159/000536576.
    PubMed     Abstract available
    
    
    
20. POTACZEK DP, Bazan-Socha S, Wypasek E, Wygrecka M, et al
    Recent Developments in the Role of Histone Acetylation in Asthma.
    Int Arch Allergy Immunol. 2024 Mar 22:1-11. doi: 10.1159/000536460.
    PubMed     Abstract available
    
    
    
21. BOWMAN WS, Schmidt RJ, Sanghar GK, Thompson Iii GR, et al
    "Air That Once Was Breath" Part 1: Wildfire-Smoke-Induced Mechanisms of Airway Inflammation - "Climate Change, Allergy and Immunology" Special IAAI Article Collection: Collegium Internationale Allergologicum Update 2023.
    Int Arch Allergy Immunol. 2024 Mar 7:1-17. doi: 10.1159/000536578.
    PubMed     Abstract available
    
    
    
22. GUO X, Sun W, Zhang B
    Monotropein Alleviates Ovalbumin-Induced Asthma in Mouse Model by Inhibiting AKT/NF-kappaB Pathway.
    Int Arch Allergy Immunol. 2024 Mar 1:1-11. doi: 10.1159/000535450.
    PubMed     Abstract available
    
    
    
23. YU R, Wang X, Wang H, Lu X, et al
    Associations between Proton-Pump Inhibitor Usage, Allergy, and Asthma: An Analysis of NHANES 2005-2006.
    Int Arch Allergy Immunol. 2024 Mar 1:1-8. doi: 10.1159/000535156.
    PubMed     Abstract available
    
    
    January 2024
24. SHU M, Xu H, Liang Y, Shi M, et al
    Long Non-Coding RNA BCYRN1 Drives Cellular Processes to Promote Asthma Development.
    Int Arch Allergy Immunol. 2024 Jan 15:1-12. doi: 10.1159/000535868.
    PubMed     Abstract available
    
    
    
25. LIN L, Dai F, Wei J, Chen Z, et al
    Biological Roles of 5-Oxo-6,8,11,14-Eicosatetraenoic Acid and the OXE Receptor in Allergic Diseases: Collegium Internationale Allergologicum Update 2024.
    Int Arch Allergy Immunol. 2024 Jan 4:1-10. doi: 10.1159/000535560.
    PubMed     Abstract available
    
    
    
26. MATSUNO O
    Factors Affecting the Ability to Discontinue Oral Corticosteroid Use in Patients with EGPA Treated with Anti-Interleukin-5 Therapy.
    Int Arch Allergy Immunol. 2024;185:116-123.
    PubMed     Abstract available
    
    
    
27. CAKMAK ME, Yegit OO, Oztop N
    A Case-Control Study Comparing the General Characteristics of Patients with Symptomatic Dermographism and Chronic Spontaneous Urticaria: Is Atopy a Risk Factor for Symptomatic Dermographism?
    Int Arch Allergy Immunol. 2024;185:247-252.
    PubMed     Abstract available
    
    
    
28. HANZAWA S, Sugiura M, Nakae S, Masuo M, et al
    The Prostaglandin D2 Receptor CRTH2 Contributes to Airway Hyperresponsiveness during Airway Inflammation Induced by Sensitization without an Adjuvant in Mice.
    Int Arch Allergy Immunol. 2024;185:752-760.
    PubMed     Abstract available
    
    
    
29. CIHANBEYLERDEN M, Tuncay G, Kayikci H, Damadoglu E, et al
    Comparison of the Efficacy of Omalizumab and Mepolizumab in Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease.
    Int Arch Allergy Immunol. 2024;185:947-952.
    PubMed     Abstract available
    
    
    December 2023
30. LIU L, Tian F, Sun Y, Li G, et al
    Exploring the Autoimmune Pathogenesis in Severe Asthma.
    Int Arch Allergy Immunol. 2023 Dec 7:1-7. doi: 10.1159/000535310.
    PubMed     Abstract available
    
    
    November 2023
31. BRAVO-GUTIERREZ FJ, Miralles-Lopez JC, Valverde-Molina J, Alemany Frances ML, et al
    Effectiveness of Mepolizumab in Patients with Severe Eosinophilic Asthma with/without Nasal Polyposis: A Real-Life Study.
    Int Arch Allergy Immunol. 2023 Nov 30:1-7. doi: 10.1159/000534902.
    PubMed     Abstract available
    
    
    
32. CAKMAK ME, Oztop N, Yegit OO
    Comparison of the General Characteristics of Patients with Severe Asthma Who Switched from Omalizumab to Mepolizumab versus Patients Who Responded to Omalizumab Treatment: A Real-Life Study.
    Int Arch Allergy Immunol. 2023 Nov 22:1-9. doi: 10.1159/000534907.
    PubMed     Abstract available
    
    
    
33. LIU HM, Rayner A, Mendelsohn AR, Shneyderman A, et al
    Applying Artificial Intelligence to Identify Common Targets for Treatment of Asthma, Eczema, and Food Allergy.
    Int Arch Allergy Immunol. 2023 Nov 21:1-12. doi: 10.1159/000534827.
    PubMed     Abstract available
    
    
    October 2023
34. OGUZULGEN K, Ozturk AB, Bacceoglu A, Aydin O, et al
    Inhaler Steroid Use Changes Oral and Airway Bacterial and Fungal Microbiome Profile in Asthma Patients.
    Int Arch Allergy Immunol. 2023 Oct 16:1-10. doi: 10.1159/000531866.
    PubMed     Abstract available
    
    
    September 2023
35. CHIANG TY, Lee HY, Chien WC, Su HC, et al
    The Relationship between Allergic Disease and Sexual Dysfunction: A Scoping Review.
    Int Arch Allergy Immunol. 2023 Sep 20:1-13. doi: 10.1159/000533403.
    PubMed     Abstract available
    
    
    
36. TONG N, Liu D, Lu L, Lin R, et al
    miR-410 Regulates Helper T Cell Differentiation in Ovalbumin-Induced Asthma through the PI3K-AKT-VEGF Signaling Pathway.
    Int Arch Allergy Immunol. 2023 Sep 19:1-9. doi: 10.1159/000531493.
    PubMed     Abstract available
    
    
    
37. LI Y, Zou C, Li J, Wang W, et al
    Airway Microbiome Composition and Co-Occurrence Network Are Associated with Inflammatory Phenotypes of Asthma.
    Int Arch Allergy Immunol. 2023 Sep 8:1-10. doi: 10.1159/000533315.
    PubMed     Abstract available
    
    
    
38. WANG H, Wang J, Song Z, Guo J, et al
    Risk Factors for Acute Rhinosinusitis in Childhood Asthma.
    Int Arch Allergy Immunol. 2023 Sep 5:1-5. doi: 10.1159/000533329.
    PubMed     Abstract available
    
    
    August 2023
39. SATO E, Seo Y, Tagaya E, Yagi O, et al
    Higher Prevalence and Severity of Eosinophilic Otitis Media in Patients with Asthma-COPD Overlap Compared with Asthma Alone.
    Int Arch Allergy Immunol. 2023 Aug 24:1-10. doi: 10.1159/000531980.
    PubMed     Abstract available
    
    
    
40. SHIMIZU M, Kato T, Adachi Y, Wada T, et al
    Maternal Dietary Vitamin D Intake during Pregnancy Is Associated with Allergic Disease Symptoms in Children at 3 Years Old: The Japan Environment and Children's Study.
    Int Arch Allergy Immunol. 2023 Aug 22:1-10. doi: 10.1159/000531970.
    PubMed     Abstract available
    
    
    
41. GUO J, Wang J, Xu X, Yang Y, et al
    Risk Factors for Abnormal Small Airway Function Indicators in Nasal Polyp Patients with and without Asthma.
    Int Arch Allergy Immunol. 2023 Aug 18:1-7. doi: 10.1159/000532068.
    PubMed     Abstract available
    
    
    
42. CAO J, Liu M, Wang Z, Huang Y, et al
    Interaction between Serum Cotinine and Magnesium Intake with Childhood Asthma: A Cross-Sectional Study.
    Int Arch Allergy Immunol. 2023 Aug 18:1-9. doi: 10.1159/000531730.
    PubMed     Abstract available
    
    
    
43. XU C, Du L, Guo Y, Liang Y, et al
    TCN1 Expression Is Increased in Asthma.
    Int Arch Allergy Immunol. 2023 Aug 16:1-8. doi: 10.1159/000531073.
    PubMed     Abstract available
    
    
    
44. STRUSS N, Dieter S, Schwarz K, Badorrek P, et al
    Sodium Chloride versus Lactose as a Carrier for House Dust Mite Allergen in Allergen Chamber Studies: A Clinical Study to Assess Noninferiority.
    Int Arch Allergy Immunol. 2023 Aug 16:1-10. doi: 10.1159/000531878.
    PubMed     Abstract available
    
    
    July 2023
45. YILDIZ E, Colkesen F, Arslan S, Evcen R, et al
    Allergic Diseases as a Clinical Phenotype Marker in Patients with Common Variable Immunodeficiency.
    Int Arch Allergy Immunol. 2023 Jul 20:1-9. doi: 10.1159/000530901.
    PubMed     Abstract available
    
    
    
46. GAO Y, Li J, Xu X, Wang C, et al
    Sensitisation to House Dust Mite Component Der p 23 Is Associated with Severe Symptoms and Asthma in Allergic Rhinitis Patients.
    Int Arch Allergy Immunol. 2023 Jul 12:1-8. doi: 10.1159/000531244.
    PubMed     Abstract available
    
    
    June 2023
47. SIO YY, Gan WL, Ng WS, Matta SA, et al
    The ERBB2 Exonic Variant Pro1170Ala Modulates Mitogen-Activated Protein Kinase Signaling Cascades and Associates with Allergic Asthma.
    Int Arch Allergy Immunol. 2023 Jun 19:1-12. doi: 10.1159/000530960.
    PubMed     Abstract available
    
    
    
48. GU Z, Wei P, Kou W, Tang XY, et al
    Analysis of Multimorbidity of Moderate to Severe Allergic Rhinitis in Children: A Real-World Study.
    Int Arch Allergy Immunol. 2023 Jun 8:1-11. doi: 10.1159/000530842.
    PubMed     Abstract available
    
    
    May 2023
49. SAKAI N, Koya T, Murai Y, Tsubokawa F, et al
    Effect of Benralizumab on Mucus Plugs in Severe Eosinophilic Asthma.
    Int Arch Allergy Immunol. 2023 May 16:1-9. doi: 10.1159/000530392.
    PubMed     Abstract available
    
    
    
50. SIO YY, Shi P, Matta SA, Fok YTR, et al
    Functional Polymorphisms of the Arachidonic Acid Pathway Associate with Risks and Clinical Outcomes of Allergic Diseases.
    Int Arch Allergy Immunol. 2023;184:609-623.
    PubMed     Abstract available
    
    
    March 2023
51. OHBAYASHI H, Hozawa S, Bertran A, Yoshisue H, et al
    Prevalence of Uncontrolled Asthma despite Treatment with Medium- or High-Dose ICS/LABA Using Patient-Reported Outcomes in Japan: The KOCU (KnOwing the Controlled statUs of Asthma in Japan) Study.
    Int Arch Allergy Immunol. 2023 Mar 30:1-12. doi: 10.1159/000529251.
    PubMed     Abstract available
    
    
    
52. CAKMAK ME, Oztop N, Yegit OO, Ozdedeoglu O, et al
    Evaluation of the Clinical Features and Laboratory Data of Patients with Severe Eosinophilic Asthma Classified as Super-Responders, Partial Responders, or Nonresponders to Mepolizumab Treatment: A Real-Life Study.
    Int Arch Allergy Immunol. 2023 Mar 30:1-8. doi: 10.1159/000529760.
    PubMed     Abstract available
    
    
    
53. YUKSEL ASLIER NG, Saatci O, Aslier M
    Disease and Quality of Life Aspects of Cat Allergy in Non-Pet Owners with Allergic Rhinitis.
    Int Arch Allergy Immunol. 2023 Mar 29:1-9. doi: 10.1159/000529275.
    PubMed     Abstract available
    
    
    February 2023
54. WANG D, Ito C, Homma Y, Arimitsu M, et al
    Prevalence and Clinical Characteristics of Patients with Moderate-to-Severe Asthma in Japan Using a JMDC Claims Database.
    Int Arch Allergy Immunol. 2023 Feb 16:1-9. doi: 10.1159/000528987.
    PubMed     Abstract available
    
    
    January 2023
55. XU C, Du L, Guo Y, Liang Y, et al
    Differential Circular RNA Expression Profiles in Induced Sputum of Patients with Asthma.
    Int Arch Allergy Immunol. 2023 Jan 23:1-11. doi: 10.1159/000528129.
    PubMed     Abstract available
    
    
    
56. ROGER A, Lazo C, Arias N, Quirant B, et al
    Using Component-Resolved Diagnosis to Characterize the Sensitization to Specific Cat and Dog Allergens in Patients with Allergic Respiratory Diseases in Catalonia, Spain.
    Int Arch Allergy Immunol. 2023 Jan 19:1-7. doi: 10.1159/000528643.
    PubMed     Abstract available
    
    
    
57. FENG H, Xiong X, Chen Z, Xu Q, et al
    Prevalence and Influencing Factors of Food Allergy in Global Context: A Meta-Analysis.
    Int Arch Allergy Immunol. 2023 Jan 12:1-33. doi: 10.1159/000527870.
    PubMed     Abstract available
    
    
    
58. ZHANG Z, Li G, Yu L, Jiang J, et al
    Using a Two-Sample Mendelian Randomization Study Based on Genome-Wide Association Studies to Assess and Demonstrate the Causal Effects of Allergic Rhinitis on Chronic Lower Respiratory Diseases and Lung Function.
    Int Arch Allergy Immunol. 2023 Jan 11:1-9. doi: 10.1159/000528350.
    PubMed     Abstract available
    
    
    
59. BU ML, Li MH, Feng M, Wang JR, et al
    Poly(I:C) Exacerbates Airway Goblet Cell Hyperplasia and Lung Inflammation in HDM-Exposed Balb/C Mice by YAP/FOXM1 Pathway.
    Int Arch Allergy Immunol. 2023;184:707-719.
    PubMed     Abstract available
    
    
    
60. SATO S, Kawano T, Ike E, Takahashi K, et al
    IL-1beta Derived Th17 Immune Responses Are a Critical Factor for Neutrophilic-Eosinophilic Airway Inflammation on Psychological Stress-Induced Immune Tolerance Breakdown in Mice.
    Int Arch Allergy Immunol. 2023;184:797-807.
    PubMed     Abstract available
    
    
    December 2022
61. PATCHETT BJ, Nriagu BN, Mavraj G, Patel RR, et al
    Allergic Polysensitization Clusters: Newly Recognized Severity Marker in Urban Asthmatic Adults.
    Int Arch Allergy Immunol. 2022 Dec 21:1-12. doi: 10.1159/000526706.
    PubMed     Abstract available
    
    
    
62. ABBASI-DOKHT T, Sadrifar S, Forouzandeh S, Malek F, et al
    Multistrain Probiotics Supplement Alleviates Asthma Symptoms via Increasing Treg Cells Population: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Int Arch Allergy Immunol. 2022 Dec 9:1-11. doi: 10.1159/000526739.
    PubMed     Abstract available
    
    
    
63. TSUBOKAWA F, Koya T, Murai Y, Tanaka K, et al
    Effects of Benralizumab on Three-Dimensional Computed Tomography Analysis in Severe Eosinophilic Asthma.
    Int Arch Allergy Immunol. 2022 Dec 5:1-9. doi: 10.1159/000525846.
    PubMed     Abstract available
    
    
    
64. AKARSU A, Oksel Karakus C, Ocak M, Oral N, et al
    Exploring the Heterogeneity of IgE-Mediated Food Allergy through Latent Class Analysis.
    Int Arch Allergy Immunol. 2022 Dec 5:1-8. doi: 10.1159/000527534.
    PubMed     Abstract available
    
    
    
65. HOTTA M, Ueda K, Ikehara S, Tanigawa K, et al
    The Duration of Neonatal Phototherapy and Allergic Disorders: The Japan Environment and Children's Study.
    Int Arch Allergy Immunol. 2022 Dec 5:1-9. doi: 10.1159/000527381.
    PubMed     Abstract available
    
    
    November 2022
66. LYLY A, Genberg E, Kauppi P, Virkkula P, et al
    Real-Life Experience of Biologic Treatment for Asthma on Chronic Rhinosinusitis: A Finnish Cohort.
    Int Arch Allergy Immunol. 2022 Nov 7:1-12. doi: 10.1159/000526365.
    PubMed     Abstract available
    
    
    
67. YAVUZ ST, Koc O, Kaya G, Gulec M, et al
    Risk Factors for Exacerbations in School-Age Children with Asthma.
    Int Arch Allergy Immunol. 2022 Nov 3:1-7. doi: 10.1159/000527220.
    PubMed     Abstract available
    
    
    October 2022
68. SUN Y, Xia T, Ma J, Sun Y, et al
    IL-12 Contributes to the Development of Asthma by Targeting HIF-1alpha/NLRP3 Pathway through Runx3.
    Int Arch Allergy Immunol. 2022 Oct 12:1-10. doi: 10.1159/000526803.
    PubMed     Abstract available
    
    
    
69. KIM MH, Sohn KH, Park HJ, Nam YH, et al
    Multicenter Prospective Observational Study to Evaluate the Therapeutic Effect and Safety of a Combination of Montelukast and Levocetirizine for Allergic Rhinitis when Administered to Patients with Allergic Rhinitis and Asthma.
    Int Arch Allergy Immunol. 2022 Oct 7:1-8. doi: 10.1159/000526094.
    PubMed     Abstract available
    
    
    
70. KAMA Y, Yamada Y, Koike T, Enseki M, et al
    Allergic Sensitization Is Crucial for the Suppressive Role of Streptococcus pneumoniae in the Acute Exacerbation of Asthma.
    Int Arch Allergy Immunol. 2022 Oct 6:1-11. doi: 10.1159/000526408.
    PubMed     Abstract available
    
    
    September 2022
71. GIULIANO AFM, Buquicchio R, Patella V, Bedbrook A, et al
    Rediscovering Allergic Rhinitis: The Use of a Novel mHealth Solution to Describe and Monitor Health-Related Quality of Life in Elderly Patients.
    Int Arch Allergy Immunol. 2022 Sep 6:1-11. doi: 10.1159/000525595.
    PubMed     Abstract available
    
    
    
72. DU L, Xu C, Shi J, Tang L, et al
    Elevated CXCL14 in Induced Sputum Was Associated with Eosinophilic Inflammation and Airway Obstruction in Patients with Asthma.
    Int Arch Allergy Immunol. 2022 Sep 5:1-10. doi: 10.1159/000526367.
    PubMed     Abstract available
    
    
    August 2022
73. ARSLAN B, Pacaci Cetin G, Turk M, Gulmez I, et al
    Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment?
    Int Arch Allergy Immunol. 2022 Aug 2:1-7. doi: 10.1159/000525723.
    PubMed     Abstract available
    
    
    June 2022
74. YANG Y, Huang G, Xu Q, Zhao G, et al
    miR-146a-5p Attenuates Allergic Airway Inflammation by Inhibiting the NLRP3 Inflammasome Activation in Macrophages.
    Int Arch Allergy Immunol. 2022 Jun 3:1-12. doi: 10.1159/000524718.
    PubMed     Abstract available
    
    
    May 2022
75. KOJIMA R, Shinohara R, Kushima M, Horiuchi S, et al
    Prenatal Negative Life Events and Childhood Allergies: The Japan Environment and Children's Study (JECS).
    Int Arch Allergy Immunol. 2022 May 19:1-9. doi: 10.1159/000524854.
    PubMed     Abstract available
    
    
    
76. ZONG W, Liang Y, Mo Y
    Increased SERPINB10 Expression in Induced Sputum Was Associated with Airway Type 2 Inflammation in Asthma.
    Int Arch Allergy Immunol. 2022 May 6:1-7. doi: 10.1159/000524613.
    PubMed     Abstract available
    
    
    April 2022
77. CHEN L, Wang W, Leng Q, Cong L, et al
    Associations of the Methylation Levels of NFAT5, PVT1, RPS6KA1, and MIB1 with Steroid-Resistant Asthma.
    Int Arch Allergy Immunol. 2022 Apr 13:1-12. doi: 10.1159/000524080.
    PubMed     Abstract available
    
    
    March 2022
78. HUANG QP, Xie ZF, Huang J
    Assessment of the Association between Genetic Polymorphisms in the CHI3L1 Gene and Asthma Risk.
    Int Arch Allergy Immunol. 2022 Mar 25:1-12. doi: 10.1159/000522393.
    PubMed     Abstract available
    
    
    February 2022
79. ZONG W, Mo Y, Liang Y
    Correlation between Increased Monocyte Chemotactic Protein 1 Level and Lung Function in Patients with Asthma.
    Int Arch Allergy Immunol. 2022 Feb 23:1-9. doi: 10.1159/000521946.
    PubMed     Abstract available
    
    
    
80. SCHIFFER M, Peters K, Peters M
    Comparison of Airway Remodeling in Two Different Endotypes of Allergic Asthma.
    Int Arch Allergy Immunol. 2022 Feb 22:1-12. doi: 10.1159/000522189.
    PubMed     Abstract available
    
    
    
81. XU C, Du L, Zeng Z, Chen F, et al
    Elevated CEACAM5 Levels in Patients with Asthma.
    Int Arch Allergy Immunol. 2022 Feb 16:1-9. doi: 10.1159/000521754.
    PubMed     Abstract available
    
    
    
82. FENG Y, Zhang S, Shang Y, Chen N, et al
    The Use of Exercise Challenge Testing and Fractional Exhaled Nitric Oxide in Diagnosis of Chest Tightness Variant Asthma in Children.
    Int Arch Allergy Immunol. 2022 Feb 14:1-8. doi: 10.1159/000522062.
    PubMed     Abstract available
    
    
    
83. RYDELL N, Nagao M, Moverare R, Ekoff H, et al
    Serum Eosinophilic Cationic Protein Is a Reliable Biomarker for Childhood Asthma.
    Int Arch Allergy Immunol. 2022 Feb 10:1-9. doi: 10.1159/000521890.
    PubMed     Abstract available
    
    
    January 2022
84. TAKEUCHI H, Takanashi S, Hasan SMT, Hore SK, et al
    Anti-Ascaris IgE as a Risk Factor for Asthma Symptoms among 5-Year-Old Children in Rural Bangladesh with Even Decreased Ascaris Infection Prevalence.
    Int Arch Allergy Immunol. 2022 Jan 31:1-11. doi: 10.1159/000521717.
    PubMed     Abstract available
    
    
    
85. KAMA Y, Yamada Y, Koike T, Suzuki K, et al
    Antibiotic Treatments Prolong the Wheezing Period in Acute Exacerbation of Childhood Bronchial Asthma.
    Int Arch Allergy Immunol. 2022 Jan 24:1-11. doi: 10.1159/000521192.
    PubMed     Abstract available
    
    
    
86. FILIOU A, Holmdahl I, Asarnoj A, van Hage M, et al
    Development of Sensitization to Multiple Allergen Molecules from Preschool to School Age Is Related to Asthma.
    Int Arch Allergy Immunol. 2022 Jan 18:1-12. doi: 10.1159/000521324.
    PubMed     Abstract available
    
    
    
87. FUKUMITSU K, Nishiyama H, Kanemitsu Y, Takeda N, et al
    Pretreatment Alveolar Nitric Oxide Levels Predict Improvement of Pulmonary Function 1 Year Following Anti-Asthma Treatments in Patients with Inhaled Corticosteroid-Naive Asthma.
    Int Arch Allergy Immunol. 2022 Jan 14:1-11. doi: 10.1159/000520508.
    PubMed     Abstract available
    
    
    
88. SOTO A, Perrone Sibilia M, Sanchez VR, Arcon N, et al
    Contribution of Kazal-Like Domains of the Serine Protease Inhibitor-1 from Toxoplasma gondii in Asthma Therapeutic Vaccination Effectiveness.
    Int Arch Allergy Immunol. 2022 Jan 11:1-8. doi: 10.1159/000520796.
    PubMed     Abstract available
    
    
    
89. MING X, Yu X, Li J, Wang J, et al
    Salidroside Attenuates Airway Inflammation and Remodeling via the miR-323-3p/SOCS5 Axis in Asthmatic Mice.
    Int Arch Allergy Immunol. 2022;183:424-434.
    PubMed     Abstract available
    
    
    
90. WANG Z, Zhang J, Yan H, Dong L, et al
    Kawasaki Disease and Atopic Diseases: A Systematic Review and Meta-Analysis of Observational Studies.
    Int Arch Allergy Immunol. 2022;183:389-397.
    PubMed     Abstract available
    
    
    
91. YOOMA P, Manuyakorn W, Sawatchai A, Jotikasthira W, et al
    Serum Periostin Predicts Wheezing Exacerbation: A Prospective Study in Preschool Children with Recurrent Wheezing.
    Int Arch Allergy Immunol. 2022;183:271-278.
    PubMed     Abstract available
    
    
    
92. LIU Y, Zhang M, Zhang H, Qian X, et al
    Anthocyanins Inhibit Airway Inflammation by Downregulating the NF-kappaB Pathway via the miR-138-5p/SIRT1 Axis in Asthmatic Mice.
    Int Arch Allergy Immunol. 2022;183:539-551.
    PubMed     Abstract available
    
    
    
93. LUAN X, Cui C, Jiang J, Wang C, et al
    Salidroside Mitigates Airway Inflammation in Asthmatic Mice via the AMPK/Akt/GSK3beta Signaling Pathway.
    Int Arch Allergy Immunol. 2022;183:326-336.
    PubMed     Abstract available
    
    
    
94. ZHANG Y, Yan L, Yang J, Li X, et al
    Silencing of FSTL1 Alleviated LPS-Induced Inflammatory Damage and Oxidative Damage in Human Bronchial Epithelial Cells via BMP4/KLF4 Axis.
    Int Arch Allergy Immunol. 2022;183:785-795.
    PubMed     Abstract available
    
    
    
95. PUXEDDU I, Petrelli F, Cristofani-Mencacci L, Scarano M, et al
    Component-Resolved Diagnosis for Endotyping Patients with Chronic Rhinosinusitis with Nasal Polyps.
    Int Arch Allergy Immunol. 2022;183:770-777.
    PubMed     Abstract available
    
    
    
96. LOPEZ-RODRIGUEZ R, Rial MJ, Esteban-Gorgojo I, Veleiro Perez B, et al
    Serodominance Profile in a Dust Mite Complex Region.
    Int Arch Allergy Immunol. 2022;183:843-851.
    PubMed     Abstract available
    
    
    
97. HAN J, Wang W, Zhu Z, Wang L, et al
    Profile of Tissue Immunoglobulin E in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps.
    Int Arch Allergy Immunol. 2022;183:835-842.
    PubMed     Abstract available
    
    
    
98. LI J, Wang X, Su Y, Hu S, et al
    TRIM33 Modulates Inflammation and Airway Remodeling of PDGF-BB-Induced Airway Smooth-Muscle Cells by the Wnt/beta-Catenin Pathway.
    Int Arch Allergy Immunol. 2022;183:1127-1136.
    PubMed     Abstract available
    
    
    
99. OZDEL OZTURK B, Yavuz Z, Aydin O, Mungan D, et al
    Effectiveness of Low-Dose Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Real-Life Experience.
    Int Arch Allergy Immunol. 2022;183:1281-1290.
    PubMed     Abstract available
    
    
    December 2021
100. GOKMIRZA OZDEMIR P, Celik V
     Current Recommendations on the Management of Pediatric Asthma and Allergic Rhinitis during the COVID-19 Pandemic versus Real-Life Practice.
     Int Arch Allergy Immunol. 2021 Dec 28:1-8. doi: 10.1159/000521117.
     PubMed     Abstract available
     
     
     
101. HE R, Chen Y, Chen X, Yuan B, et al
     Mechanism of miR-181a-5p in Regulatory T/T-Helper 17 Immune Imbalance and Asthma Development in Mice with Allergic Rhinitis.
     Int Arch Allergy Immunol. 2021 Dec 23:1-14. doi: 10.1159/000519703.
     PubMed     Abstract available
     
     
     
102. OZDEL OZTURK B, Yavuz Z, Eraslan D, Mungan D, et al
     Mepolizumab Is an Effective Option in Severe Eosinophilic Asthma Regardless of Baseline Features: Single-Center Real-Life Data.
     Int Arch Allergy Immunol. 2021 Dec 14:1-13. doi: 10.1159/000520725.
     PubMed     Abstract available
     
     
     
103. REINSBERG M, Siebert S, Dreher C, Bogs T, et al
     Predictors of Airway Hyperresponsiveness in Symptomatic Children with Normal Spirometry and Suspicious of Possible Asthma.
     Int Arch Allergy Immunol. 2021 Dec 10:1-9. doi: 10.1159/000520670.
     PubMed     Abstract available
     
     
     October 2021
104. TORRE E, Sola D, Caramaschi A, Mignone F, et al
     A Pilot Study on Clinical Scores, Immune Cell Modulation, and Microbiota Composition in Allergic Patients with Rhinitis and Asthma Treated with a Probiotic Preparation.
     Int Arch Allergy Immunol. 2021 Oct 21:1-15. doi: 10.1159/000518952.
     PubMed     Abstract available
     
     
     
105. ALABED M, Sultana Shaik A, Saheb Sharif-Askari N, Saheb Sharif-Askari F, et al
     Enhanced Infiltration of Central Memory T Cells to the Lung Tissue during Allergic Lung Inflammation.
     Int Arch Allergy Immunol. 2021 Oct 20:1-15. doi: 10.1159/000518835.
     PubMed     Abstract available
     
     
     
106. KOYA T, Sakai N, Sasaki T, Shinbori K, et al
     Effect of Dupilumab on Depression in Asthma with Eosinophilic Chronic Rhinosinusitis in the Japanese Population.
     Int Arch Allergy Immunol. 2021 Oct 15:1-9. doi: 10.1159/000519296.
     PubMed     Abstract available
     
     
     
107. PAN HH, Ko JL, Wu CT, Sun HL, et al
     Effect of the Fungal Immunomodulatory Protein FIP-fve in the Neutrophilic Asthma Animal Model.
     Int Arch Allergy Immunol. 2021 Oct 14:1-12. doi: 10.1159/000517184.
     PubMed     Abstract available
     
     
     September 2021
108. INOUE H, Akimoto K, Ikeda H, Sato H, et al
     Comprehensive Gene Expression Signature Using RNA-Seq in Airways of Mouse Model of Severe Asthma with Fungal Sensitization.
     Int Arch Allergy Immunol. 2021 Sep 29:1-11. doi: 10.1159/000519172.
     PubMed     Abstract available
     
     
     
109. VENTURA MT, Giuliano AFM, Buquicchio R, Bedbrook A, et al
     Implementation of the MASK-Air(R) App for Rhinitis and Asthma in Older Adults: MASK@Puglia Pilot Study.
     Int Arch Allergy Immunol. 2021 Sep 22:1-6. doi: 10.1159/000518032.
     PubMed     Abstract available
     
     
     
110. SAHINER UM, Arik Yilmaz E, Fontanella S, Haider S, et al
     The Montelukast Therapy in Asthmatic Children with and without Food Allergy: Does It Make Any Difference?
     Int Arch Allergy Immunol. 2021 Sep 9:1-10. doi: 10.1159/000517865.
     PubMed     Abstract available
     
     
     January 2021
111. METBULUT AP, Mustafaoglu O, Sen G, Kanik Yuksek S, et al
     Evaluation of the Clinical and Laboratory Findings of Asthmatic Children with SARS-CoV-2 Infection.
     Int Arch Allergy Immunol. 2021;182:989-996.
     PubMed     Abstract available
     
     
     
112. HE Y, Liu J, Zhao D, Zhang S, et al
     The IgE Blocking Activity Induced by Dermatophagoides pteronyssinus Subcutaneous Immunotherapy Does Not Correlate with Specific IgA but with IgG4 in both Serum and Saliva.
     Int Arch Allergy Immunol. 2021;182:1231-1244.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge.